{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:11:41Z","timestamp":1789056701139,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Artif Organs"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vaccination is among the cornerstones of infectious disease prevention in heart transplant candidates and recipients. Guidelines recommend an inactivated hepatitis A virus vaccine for heart transplant candidates, many of whom are on ventricular assist devices and at risk of hepatitis A virus exposure. However, data on the immunogenicity and safety of hepatitis A virus vaccines in these patients are lacking.This retrospective, observational, single-center study was conducted at our outpatient clinic between December 2019 and December 2025. The study participants were heart transplant candidates with ventricular assist devices aged \u226516 years who tested negative for anti-hepatitis A virus immunoglobulin G at baseline and completed the inactivated hepatitis A virus vaccination series. Anti-hepatitis A virus immunoglobulin G titers were measured after vaccination using a chemiluminescent immunoassay. Thirty-five individuals were included in the study. Immunosuppressive agents were used in four patients (11.4%). All participants achieved seroconversion at a median of 1 month after vaccination. The reverse cumulative distribution of the Anti-hepatitis A virus immunoglobulin G sample\/cutoff values indicated that an adequate antibody response was achieved in individuals with ventricular assist devices. Adverse events of the vaccine were minor; two patients (6%) experienced local pain, and two (6%) subcutaneous hemorrhage. Seroconversion in patients with ventricular assist devices was high. hepatitis A virus vaccination should be completed before transplantation in heart transplant candidates, if indicated.<\/jats:p>","DOI":"10.1007\/s10047-026-01579-2","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T13:11:47Z","timestamp":1786108307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis A vaccination during ventricular assist device support in heart transplant candidates: immunogenicity and safety in a single-center cohort"],"prefix":"10.1007","volume":"29","author":[{"given":"Masahiro","family":"Arima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-7256","authenticated-orcid":false,"given":"Shinya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8960-8212","authenticated-orcid":false,"given":"Maho","family":"Adachi-Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4072-9096","authenticated-orcid":false,"given":"Koh","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-8291","authenticated-orcid":false,"given":"Shu","family":"Okugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0851-1887","authenticated-orcid":false,"given":"Takeya","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"7","key":"1579_CR1","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1093\/cid\/ciz1113","volume":"71","author":"C van Delden","year":"2020","unstructured":"van Delden C, Stampf S, Hirsch HH, Manuel O, Meylan P, Cusini A, Hirzel C, Khanna N, Weisser M, Garzoni C, et al. Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study. Clin Infect Dis. 2020;71(7):e159\u201369.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1579_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6905a1","volume":"69","author":"NP Nelson","year":"2020","unstructured":"Nelson NP, Weng MK, Hofmeister MG, Moore KL, Doshani M, Kamili S, Koneru A, Haber P, Hagan L, Romero JR, et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep. 2020;69(5):1\u201338.","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"1579_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/cit816","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309\u201318.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1579_CR4","doi-asserted-by":"publisher","first-page":"e13563","DOI":"10.1111\/ctr.13563","volume":"33","author":"L Danziger-Isakov","year":"2019","unstructured":"Danziger-Isakov L, Kumar D, AST Infectious Diseases Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transpl. 2019;33(9):e13563.","journal-title":"Clin Transpl"},{"issue":"Suppl 4","key":"1579_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/ajt.12122","volume":"13","author":"L Danziger-Isakov","year":"2013","unstructured":"Danziger-Isakov L, Kumar D. AST Infectious Diseases Community of Practice: Vaccination in solid organ transplantation. Am J Transpl. 2013;13(Suppl 4):311\u20137.","journal-title":"Am J Transpl"},{"issue":"47","key":"1579_CR6","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1016\/j.vaccine.2017.10.002","volume":"35","author":"S Fukushima","year":"2017","unstructured":"Fukushima S, Kiyohara T, Ishii K, Nakano T, Hamada A. Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix\u00ae) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen\u00ae) for Japanese travelers to endemic countries. Vaccine. 2017;35(47):6412\u20135.","journal-title":"Vaccine"},{"issue":"41","key":"1579_CR7","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1016\/j.vaccine.2023.08.030","volume":"41","author":"Y Maki","year":"2023","unstructured":"Maki Y, Edo N, Mizuguchi M, Ikeda M, Kitano M, Kitagami E, Osa M, Yamamoto S, Ogawa T, Nakamura T, et al. Impact of frequency and duration of freeze-dried inactivated tissue culture hepatitis A vaccine (Aimmugen\u00ae) vaccination on antibody titers; a japanese cross-sectional study. Vaccine. 2023;41(41):5974\u20138.","journal-title":"Vaccine"},{"issue":"9596","key":"1579_CR8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"issue":"2","key":"1579_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/ehf2.13798","volume":"9","author":"O Itzhaki Ben Zadok","year":"2022","unstructured":"Itzhaki Ben Zadok O, Shaul AA, Ben-Avraham B, Yaari V, Ben Zvi H, Eliakim-Raz N, Yahav D, Abed G, Abuhazira M, Barac YD, et al. Six-months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device-supported patients. ESC Heart Fail. 2022;9(2):905\u201311.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"1579_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/jhep.2001.25883","volume":"34","author":"MR Arguedas","year":"2001","unstructured":"Arguedas MR, Johnson A, Eloubeidi MA, Fallon MB. Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients. Hepatology. 2001;34(1):28\u201331.","journal-title":"Hepatology"},{"issue":"2","key":"1579_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1023\/A:1013734525348","volume":"47","author":"MR Arguedas","year":"2002","unstructured":"Arguedas MR, McGuire BM, Fallon MB. Implementation of vaccination in patients with cirrhosis. Dig Dis Sci. 2002;47(2):384\u20137.","journal-title":"Dig Dis Sci"},{"issue":"10","key":"1579_CR12","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/ndt\/17.10.1825","volume":"17","author":"EH Fleischmann","year":"2002","unstructured":"Fleischmann EH, Kruppenbacher J, Bock HL, Weber M. Active immunization against hepatitis A in dialysis patients. Nephrol Dial Transpl. 2002;17(10):1825\u20138.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"1579_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1440-1746.1994.tb01714.x","volume":"9","author":"I Kuramoto","year":"1994","unstructured":"Kuramoto I, Fujiyama S, Matsushita K, Sato T. Immune response after hepatitis A vaccination in haemodialysis patients: comparison with hepatitis B vaccination. J Gastroenterol Hepatol. 1994;9(3):228\u201331.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"1579_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/tid.12217","volume":"16","author":"HJ Jeon","year":"2014","unstructured":"Jeon HJ, Ro H, Jeong JC, Koo TY, Han M, Min SI, Oh KH, Ha J, Ahn C, Yang J. Efficacy and safety of hepatitis A vaccination in kidney transplant recipients. Transpl Infect Dis. 2014;16(3):511\u20135.","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"1579_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00007890-200107270-00019","volume":"72","author":"M Arslan","year":"2001","unstructured":"Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation. 2001;72(2):272\u20136.","journal-title":"Transplantation"},{"issue":"6","key":"1579_CR16","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1086\/315125","volume":"180","author":"K Stark","year":"1999","unstructured":"Stark K, Gunther M, Neuhaus R, Reinke P, Schroder K, Linnig S, Bienzle U. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis. 1999;180(6):2014\u20137.","journal-title":"J Infect Dis"},{"issue":"1","key":"1579_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41598-020-80052-3","volume":"11","author":"T Prasoppokakorn","year":"2021","unstructured":"Prasoppokakorn T, Vanichanan J, Chaiteerakij R, Jutivorakool K, Udomkarnjananun S, Pongpirul K, Taesombat W, Wattanatorn S, Avihingsanon Y, Tungsanga K, et al. A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients. Sci Rep. 2021;11(1):50.","journal-title":"Sci Rep"},{"issue":"RR\u20137","key":"1579_CR18","first-page":"1","volume":"55","author":"AE Fiore","year":"2006","unstructured":"Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR\u20137):1\u201323.","journal-title":"MMWR Recomm Rep"}],"container-title":["Journal of Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-026-01579-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10047-026-01579-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-026-01579-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:03:19Z","timestamp":1789056199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10047-026-01579-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1007\/s10047-026-01579-2","relation":{},"ISSN":["1434-7229","1619-0904"],"issn-type":[{"value":"1434-7229","type":"print"},{"value":"1619-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"3 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Artificial Heart (clinical).","order":2,"name":"Ethics","label":"Research field","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"53"}}